Learn More
Description
Specifications
Specifications
| Antigen | Sars Spike Protein |
| Applications | Western Blot, ELISA |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Dilution | Western Blot 0.5-2 ug/ml, ELISA 0.5-2 ug/ml |
| Formulation | PBS containing 0.2% gelatin with 0.05% Sodium Azide |
| Gene Alias | E2, E2 glycoprotein, Human coronavirus spike glycoprotein, Peplomer protein, S, S glycoprotein, SARS coronavirus S protein, SARS coronavirus Spike Protein, SARS CoV, SARS CoV S glycoprotein, SARS CoV Spike protein, SARSCoV, SARS-CoV S protein, SARS-COV Spike, Severe acute respiratory syndrome spike glycoprotein, Severe acute respiratory syndrome virus spike glycoprotein, Spike glycoprotein, VGL2 |
| Host Species | Rabbit |
| Immunogen | The antibody was developed by immunizing rabbits with a synthetic peptide corresponding to amino acids 19-35 (CTTFDDVQAPNYTQHTS) from the S (Spike glycoprotein)(Spike Protein 1) for the Human SARS coronavirus (Genbank accession no. NP_828851.1) |
| Show More |
For Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
